Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
<p>Abstract</p> <p>Background</p> <p>Brain metastases (BM) is one of the most common failures of locally advanced non-small cell lung cancer (LA-NSCLC) after combined-modality therapy. The outcome of trials on prophylactic cranial irradiation (PCI) has prompted us to id...
Main Authors: | Ding Xiao, Dai Honghai, Hui Zhouguang, Ji Wei, Liang Jun, Lv Jima, Zhou Zongmei, Yin Weibo, He Jie, Wang Luhua |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://www.ro-journal.com/content/7/1/119 |
Similar Items
-
The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation
by: Willem J. A. Witlox, et al.
Published: (2018-07-01) -
Does surgically resected small‐cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
by: Yuqing Lou, et al.
Published: (2020-05-01) -
Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation
by: Lei Zhao, et al.
Published: (2017-07-01) -
Prospective Exploratory Study of the Clinical Significance of Circulating Tumor Cells in Patients With Small Cell Lung Cancer Exposed to Prophylactic Cranial Irradiation
by: Lei Deng, et al.
Published: (2021-02-01) -
Adoption of prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (ES-SCLC): a population based outcome study
by: Yu Yang Soon, et al.
Published: (2018-12-01)